Literature DB >> 30045953

Chronic Activation of Liver X Receptor Sensitizes Mice to High Cholesterol Diet-Induced Gut Toxicity.

Wojciech G Garbacz1, Hirdesh Uppal1, Jiong Yan1, Meishu Xu1, Songrong Ren1, Donna B Stolz1, Min Huang1, Wen Xie2.   

Abstract

Cholesterol is essential for numerous biologic functions and processes, but an excess of intracellular cholesterol can be toxic. Intestinal cholesterol absorption is a major determinant of plasma cholesterol level. The liver X receptor (LXR) is a nuclear receptor known for its activity in cholesterol efflux and reverse cholesterol transport. In this study, we uncovered a surprising function of LXR in intestinal cholesterol absorption and toxicity. Genetic or pharmacologic activation of LXRα-sensitized mice to a high-cholesterol diet (HCD) induced intestinal toxicity and tissue damage, including the disruption of enterocyte tight junctions, whereas the same HCD caused little toxicity in the absence of LXR activation. The gut toxicity in HCD-fed LXR-KI mice may have been accounted for by the increased intestinal cholesterol absorption and elevation of enterocyte and systemic levels of free cholesterol. The increased intestinal cholesterol absorption preceded the gut toxicity, suggesting that the increased absorption was not secondary to tissue damage. The heightened sensitivity to HCD in the HCD-fed LXRα-activated mice appeared to be intestine-specific because the liver was not affected despite activation of the same receptor in this tissue. Moreover, heightened sensitivity to HCD cannot be reversed by ezetimibe, a Niemann-Pick C1-like 1 inhibitor that inhibits intestinal cholesterol absorption, suggesting that the increased cholesterol absorption in LXR-activated intestine is mediated by a mechanism that has yet to be defined.
Copyright © 2018 by The American Society for Pharmacology and Experimental Therapeutics.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30045953      PMCID: PMC6108576          DOI: 10.1124/mol.118.112672

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  39 in total

1.  Activation of LXRs prevents bile acid toxicity and cholestasis in female mice.

Authors:  Hirdesh Uppal; Simrat P S Saini; Antonio Moschetta; Ying Mu; Jie Zhou; Haibiao Gong; Yonggong Zhai; Songrong Ren; George K Michalopoulos; David J Mangelsdorf; Wen Xie
Journal:  Hepatology       Date:  2007-02       Impact factor: 17.425

Review 2.  Regulation of tight junction permeability by intestinal bacteria and dietary components.

Authors:  Dulantha Ulluwishewa; Rachel C Anderson; Warren C McNabb; Paul J Moughan; Jerry M Wells; Nicole C Roy
Journal:  J Nutr       Date:  2011-03-23       Impact factor: 4.798

Review 3.  Role of cholesterol and lipid organization in disease.

Authors:  Frederick R Maxfield; Ira Tabas
Journal:  Nature       Date:  2005-12-01       Impact factor: 49.962

4.  In vivo metabolism-based discovery of a potent cholesterol absorption inhibitor, SCH58235, in the rat and rhesus monkey through the identification of the active metabolites of SCH48461.

Authors:  M Van Heek; C F France; D S Compton; R L McLeod; N P Yumibe; K B Alton; E J Sybertz; H R Davis
Journal:  J Pharmacol Exp Ther       Date:  1997-10       Impact factor: 4.030

5.  LXRβ activation increases intestinal cholesterol absorption, leading to an atherogenic lipoprotein profile.

Authors:  X Hu; K R Steffensen; Z-Y Jiang; P Parini; J-Å Gustafsson; M Gåfvels; G Eggertsen
Journal:  J Intern Med       Date:  2012-03-26       Impact factor: 8.989

Review 6.  Atherosclerosis: lessons from LXR and the intestine.

Authors:  Barbara Bonamassa; Antonio Moschetta
Journal:  Trends Endocrinol Metab       Date:  2012-11-15       Impact factor: 12.015

7.  Different effects of the Cdx1 and Cdx2 homeobox genes in a murine model of intestinal inflammation.

Authors:  A Calon; I Gross; B Lhermitte; E Martin; F Beck; B Duclos; M Kedinger; I Duluc; C Domon-Dell; J-N Freund
Journal:  Gut       Date:  2007-06-26       Impact factor: 23.059

8.  Liver X receptor activation induces the uptake of cholesteryl esters from high density lipoproteins in primary human macrophages.

Authors:  Stephanie Bultel; Lionel Helin; Veronique Clavey; Giulia Chinetti-Gbaguidi; Elena Rigamonti; Morvane Colin; Jean-Charles Fruchart; Bart Staels; Sophie Lestavel
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-09-18       Impact factor: 8.311

9.  Transcriptional regulation of human hydroxysteroid sulfotransferase SULT2A1 by LXRα.

Authors:  Zhimin Ou; Mengxi Jiang; Bingfang Hu; Yixian Huang; Meishu Xu; Songrong Ren; Song Li; Suhuan Liu; Wen Xie; Min Huang
Journal:  Drug Metab Dispos       Date:  2014-07-15       Impact factor: 3.922

10.  LXR regulates cholesterol uptake through Idol-dependent ubiquitination of the LDL receptor.

Authors:  Noam Zelcer; Cynthia Hong; Rima Boyadjian; Peter Tontonoz
Journal:  Science       Date:  2009-06-11       Impact factor: 47.728

View more
  1 in total

1.  Intestinal Sulfation Is Essential to Protect Against Colitis and Colonic Carcinogenesis.

Authors:  Pengfei Xu; Yue Xi; Junjie Zhu; Min Zhang; Zigmund Luka; Donna B Stolz; Xinran Cai; Yang Xie; Meishu Xu; Songrong Ren; Zhiying Huang; Da Yang; John D York; Xiaochao Ma; Wen Xie
Journal:  Gastroenterology       Date:  2021-04-02       Impact factor: 33.883

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.